Rosemont Pharmaceuticals, the Leeds-based supplier of liquid medicines with 170 staff, has undergone a £93m management buy-out from US-based Savient Pharmaceuticals. The buy-out was financed by Close Brothers Private Equity and led by Rosemont's managing diector John Blythe and finance director Neil Salvin.The pair had previously attempted to buy the company from its Dutch owner Akzo-Nobel in 2002 but were beaten by Savient . Rosemont was founded in 1967 by two Leeds pharmacists under the name of RP Drugs, and Blythe joined the business as a school leaver in 1975. Sean Dinnen, a partner at Close Brothers, commented: "The company operates in a clear, growing niche and has excellent opportunities to develop its range of products and to sell internationally."